Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
The Louvi bean (Vigna unguiculata), widely known as the black-eyed pea or cowpea, is a nutrient-dense legume rich in bioactive α-amylase inhibitor proteins, polyphenolic compounds (quercetin-3-O-glucoside, kaempferol glycosides, condensed tannins), soluble dietary fiber, folate, and iron that collectively support glycemic regulation, cardiovascular health, and digestive function. Its phenolic constituents competitively inhibit pancreatic α-amylase and α-glucosidase, blunting postprandial blood glucose spikes, while its high soluble fiber content promotes gut microbiome diversity and satiety—making it a valuable functional food for metabolic and digestive wellness.
Reported Benefits (Provisional)
Origin & History
The Louvi bean (Vigna unguiculata), commonly known as black-eyed pea or cowpea, is a highly adaptable legume native to Africa. It is widely cultivated across the Mediterranean, Middle East, and South Asia, thriving in arid and semi-arid regions. Valued for its robust nutritional profile, including plant-based protein and dietary fiber, it is a foundational food for metabolic health and digestive support.
Research Narrative (Provisional)
No PubMed-indexed clinical trials specifically use the term 'Louvi bean'; however, the underlying species Vigna unguiculata (cowpea/black-eyed pea) has been extensively studied in peer-reviewed literature. Research published in Food Chemistry and the Journal of Agricultural and Food Chemistry has characterized cowpea polyphenol profiles—including flavonol glycosides, phenolic acids, and condensed tannins—demonstrating significant in vitro inhibition of pancreatic α-amylase and α-glucosidase, enzymes central to postprandial glucose metabolism. Studies in the Journal of Food Science and Technology have also documented the antioxidant capacity, mineral bioavailability, and prebiotic fiber content of cowpea varieties, supporting their role in metabolic and cardiovascular health. Future human clinical trials specifically referencing 'Louvi bean' are needed to confirm dose-response relationships in vivo.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Complex Carbohydrates - Plant-based protein - Dietary fiber - B vitamins (Folate, Niacin) - Iron - Zinc - Magnesium - Potassium - Flavonoids (kaempferol, quercetin) - Polyphenols - Saponins
Reported Mechanism (Provisional)
Louvi bean's bioactive α-amylase inhibitor proteins (αAI) bind competitively to the catalytic site of pancreatic α-amylase (EC 3.2.1.1), reducing the enzymatic hydrolysis of dietary starch into maltose and glucose and thereby attenuating the postprandial glycemic response. Its phenolic compounds—principally quercetin-3-O-glucoside, kaempferol glycosides, and condensed proanthocyanidins—further inhibit intestinal α-glucosidase (EC 3.2.1.20), slowing the release of glucose from oligosaccharides at the brush border membrane. The soluble dietary fiber fraction (galactomannans, pectins) delays gastric emptying and forms viscous gels in the small intestine that reduce glucose and cholesterol absorption, while also serving as a fermentable substrate for colonic Bifidobacterium and Lactobacillus species, generating short-chain fatty acids (acetate, propionate, butyrate) that enhance intestinal barrier integrity and modulate systemic inflammation via GPR41/GPR43 signaling. Additionally, folate and iron supplied by the bean support one-carbon metabolism and hemoglobin synthesis, contributing to cellular energy production and oxygen transport.
Clinical Narrative (Provisional)
Current clinical evidence for Louvi bean is limited, with most research focusing on related legume species in small-scale studies. White kidney bean extract studies (n=14) demonstrated gut microbiota modulation with increased Bacteroides and Prevotella genera abundance, though no significant β-diversity changes occurred. Iron-biofortified bean trials in young women (n=128, 18 weeks) showed improved hemoglobin levels (+0.5 g/dL) but no direct cognitive benefits. Larger randomized controlled trials specifically examining Louvi bean's metabolic and cardiovascular effects are needed to establish definitive clinical efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.